日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Age-dependent differences in survival of patients with early breast cancer: analysis of SUCCESS A, B, C trials

早期乳腺癌患者生存率的年龄依赖性差异:SUCCESS A、B、C 试验分析

Lukac, Stefan; Dayan, Davut; Janni, Wolfgang; Rack, Brigitte; Fink, Visnja; Veselinovic, Kristina; Pfister, Kerstin; Fink, Angelina; Friedl, Thomas W P; Leinert, Elena

Time Toxicity of Endocrine-based Oral CDK4/6 Inhibitor Therapies

内分泌靶向口服 CDK4/6 抑制剂疗法的时间毒性

Schäffler, Henning; Heublein, Sabine; Lichtblau, Julia; Wisniewski, Lisa; Rack, Brigitte; Janni, Wolfgang; Englisch, Alexander; Englisch, Johannes; Engler, Tobias; Hartkopf, Andreas; Brucker, Sara; Hilmer, Lisbeth; Fick, Franziska; Kohls, Fabian; Banys-Paluchowski, Maggie; Rody, Achim; Dannehl, Dominik; Tauber, Nikolas

Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis

PREDICT全球汇总分析中重复循环肿瘤细胞计数作为转移性乳腺癌早期治疗监测工具的临床有效性

Janni, Wolfgang; Friedl, Thomas W P; Yab, Tracy C; Bidard, Francois-Clément; Cristofanilli, Massimo; Hayes, Daniel F; Ignatiadis, Michail; Regan, Meredith M; Alix-Panabieres, Catherine; Barlow, William E; Caldas, Carlos; Carey, Lisa A; Dirix, Luc; Fehm, Tanja; Garcia-Saenz, Jose A; Gazzaniga, Paola; Generali, Daniele; Gerratana, Lorenzo; Gisbert-Criado, Rafael; Jacot, William; Jiang, Zefei; Joosse, Simon A; Lianidou, Evi; López López, Rafael; Magbanua, Mark J M; Manso, Luis; Mavroudis, Dimitris; Müller, Volkmar; Munzone, Elisabetta; Pantel, Klaus; Pierga, Jean-Yves; Rack, Brigitte; Riethdorf, Sabine; Rugo, Hope S; Sideras, Kostandinos; Sleijfer, Stefan; Smerage, Jeffrey; Stebbing, Justin; Terstappen, Leon W M M; Vidal-Martínez, Jose; Wallwiener, Markus; Giridhar, Karthik V; Liu, Minetta C

Is Radiographic Aftercare Obsolete? How Testing Positive for ctDNA Can Be a Precedent for Late Relapse, Even in Low-Risk Hormone-Receptor-Positive Breast Cancer

放射影像检查后的护理是否已经过时?ctDNA检测呈阳性如何预示着低风险激素受体阳性乳腺癌患者晚期复发?

Pfister, Kerstin; Huesmann, Sophia; Fink, Angelina; Friedl, Thomas W P; Mergel, Franziska; Schäffler, Henning P; Hartkopf, Andreas; Lukac, Stefan; Veselinovic, Kristina; Mehmeti, Forca; Campbell, Nathan; Pipinikas, Christodoulos; Deininger, Katharina; Beer, Ambros; Lorenz, Stefanie; Beer, Meinrad; Wiesmüller, Lisa; Janni, Wolfgang; Heublein, Sabine; Rack, Brigitte

Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial

绝经后激素受体阳性、HER2阴性早期乳腺癌患者接受一线来曲唑治疗后,在(新)辅助化疗后的无侵袭性疾病生存期和总生存期:来自IV期PreFace试验的经验

Beierlein, Milena; Häberle, Lothar; Nabieva, Naiba; Maass, Nicolai; Aktas, Bahriye; Kümmel, Sherko; Thomssen, Christoph; Wolf, Christopher; Kolberg, Hans-Christian; Brucker, Cosima; Janni, Wolfgang; Dall, Peter; Schneeweiss, Andreas; Marme, Frederik; Sütterlin, Marc W; Ruebner, Matthias; Theuser, Anna-Katharin; Hofmann, Nadine M; Böhm, Sybille; Almstedt, Katrin; Kellner, Sara; Gass, Paul; Lück, Hans-Joachim; Hein, Alexander; Schmatloch, Sabine; Kalder, Matthias; Uleer, Christoph; Juhasz-Böss, Ingolf; Hanf, Volker; Jackisch, Christian; Müller, Volkmar; Rack, Brigitte; Belleville, Erik; Wallwiener, Diethelm; Rody, Achim; Rauh, Claudia; Bayer, Chistian M; Uhrig, Sabrina; Huebner, Hanna; Goossens, Chloë; Brucker, Sara Y; Hack, Carolin C; Fehm, Tanja N; Fasching, Peter A

Mass cytometric detection of homologous recombination proficiency in circulating tumor cells to predict chemoresistance of metastatic breast cancer patients

利用质谱流式细胞术检测循环肿瘤细胞中同源重组能力,预测转移性乳腺癌患者的化疗耐药性

Niedermayer, Kathrin; Schäffler, Henning; Vlachos, Georgios; Greco, Sara; Pfister, Kerstin; Volz, Barbara; Ott, Leonie; Neubauer, Hans; Polzer, Bernhard; Koch, André; Riethdorf, Sabine; Fehm, Tanja; Janni, Wolfgang; Friedl, Thomas W P; Rack, Brigitte; Heitzer, Ellen; Schochter, Fabienne; Wiesmüller, Lisa

Negative Effect of Intravenous Antibiotics on Survival in Patients with Triple-Negative Breast Cancer

静脉注射抗生素对三阴性乳腺癌患者生存率的负面影响

Lukac, Stefan; Fink, Visnja; Dayan, Davut; Rack, Brigitte; Janni, Wolfgang; Lato, Krisztian; Veselinovic, Kristina; Heublein, Sabine; Friedl, Thomas Wolfram Paul; Leinert, Elena

Exploiting somatic oncogenic driver alterations in a patient with Li-Fraumeni syndrome- paving the path towards precision medicine: a case report

利用体细胞致癌驱动基因突变治疗李-弗劳梅尼综合征患者——为精准医疗铺平道路:病例报告

Seeling, Carolin; Dahlum, Sonja; Marienfeld, Ralf; Jan, Vera; Rack, Brigitte; Gerstenmaier, Uwe; Beer, Ambros J; Mayer-Steinacker, Regine; Thaiss, Wolfgang; Barth, Thomas F E; Seufferlein, Thomas; Gaisa, Nadine T; Stilgenbauer, Stephan; Janni, Wolfgang; Siebert, Reiner; Döhner, Hartmut; Gaidzik, Verena I

The SURVIVE study (NCT05658172): Bringing breast cancer aftercare to the 21stcentury: Study protocol of a Phase III clinical trial comparing liquid biopsy guided vs. Standard of care surveillance for intermediate to high-risk breast cancer survivors

SURVIVE 研究 (NCT05658172):将乳腺癌术后护理带入 21 世纪:一项 III 期临床试验的研究方案,比较液体活检指导与标准护理监测对中高危乳腺癌幸存者的影响

Braun, Tatjana; Huesmann, Sophia; Pfister, Kerstin; Friedl, Thomas W P; Hartkopf, Andreas; Pantel, Klaus; Mehmeti, Forca; Mergel, Franziska; Schäffler, Henning; Heublein, Sabine; Wiesmüller, Lisa; Rack, Brigitte; Fasching, Peter A; Janni, Wolfgang; Fink, Angelina

Study Protocol of SURVIVE HERoes (NCT06643585): Trastuzumab Deruxtecan for molecular relapse in HER2+/ Low early breast cancer with ctDNA positivity after primary therapy

SURVIVE HERoes 研究方案 (NCT06643585):曲妥珠单抗德鲁替康用于 HER2+/低危早期乳腺癌患者在接受初始治疗后出现分子复发,且 ctDNA 阳性

Pfister, Kerstin; Friedl, Thomas W P; Hartkopf, Andreas; Mergel, Franziska; Huesmann, Sophia; Mehmeti, Forca; Schäffler, Henning; Fink, Angelina; Braun, Tatjana; Heublein, Sabine; Wiesmüller, Lisa; Pantel, Klaus; Rack, Brigitte; Fasching, Peter A; Janni, Wolfgang